Da-Young Keum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Da-Young Keum has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Heejin Jo
Johns Hopkins University School of Medicine, USA
1 shared publication - Joo-Young Gwag
Department of Biomolecular Engineering and Bioinformatics, University of California, Santa Cruz, CA 95064, USA
1 shared publication - Ju-Won Lee
Neuroregeneration and Stem Cell Programs, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication - Sung-Min Jeon
Johns Hopkins University School of Medicine, USA
1 shared publication - Sung-Ung Kang
Johns Hopkins University School of Medicine, USA
1 shared publication - Yoon-Seob Lee
Department of Dentistry, College of Dentistry, Yonsei University, Seoul 03722, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 19 November 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (11) , 1241
The cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation
Dementia is a growing global health concern in aging societies, leading to a progressive decline in cognitive function that severely impairs daily life. Despite the growing burden, effective preventive and therapeutic strategies remain elusive, emphasizing the urgent need for novel interventions. Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer’s disease (AD). Chronic activation of central nervous system immune cells, particularly microglia, exacerbates neurodegeneration and establishes a self-perpetuating cycle of inflammation and cognitive decline. This review focuses on emerging research exploring the cGAS-STING pathway’s role in dementia, examining its potential as a diagnostic and therapeutic target. The cGAS-STING pathway, integral to innate immune responses, may contribute to the chronic neuroinflammation seen in neurodegenerative diseases. By targeting this pathway, new strategies could mitigate the inflammatory processes that drive neuronal loss, offering a promising avenue for therapeutic development in dementia.
- 19 November 2025
- Published by MDPI AG in Brain Sciences
- Vol. 15 (11) , 1241
Open AccessThe cGAS–STING Pathway in Dementia: An Emerging Mechanism of Neuroinflammation
Dementia is a growing global health concern in aging societies, leading to a progressive decline in cognitive function that severely impairs daily life. Despite the growing burden, effective preventive and therapeutic strategies remain elusive, emphasizing the urgent need for novel interventions. Recent advances underscore the pivotal role of neuroinflammation in dementia pathogenesis, particularly in Alzheimer’s disease (AD). Chronic activation of central nervous system immune cells, particularly microglia, exacerbates neurodegeneration and establishes a self-perpetuating cycle of inflammation and cognitive decline. This review focuses on emerging research exploring the cGAS-STING pathway’s role in dementia, examining its potential as a diagnostic and therapeutic target. The cGAS-STING pathway, integral to innate immune responses, may contribute to the chronic neuroinflammation seen in neurodegenerative diseases. By targeting this pathway, new strategies could mitigate the inflammatory processes that drive neuronal loss, offering a promising avenue for therapeutic development in dementia.